Keytruda To Enjoy First-To-Market Advantage As TNBC Approval Now More Likely

 
• By Alaric DeArment
  
Doctor with Mammography - Image
Keytruda unveils EFS data for Keytruda in triple-negative breast cancer and seeks FDA approval • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer